S&P 500   3,372.59 (-0.22%)
DOW   29,250.19 (-0.50%)
QQQ   235.01 (+0.16%)
AAPL   319.20 (-1.77%)
FB   217.33 (+1.47%)
MSFT   187.43 (+1.12%)
GOOGL   1,524.38 (+0.37%)
AMZN   2,164.46 (+1.39%)
CGC   22.23 (+0.45%)
NVDA   296.89 (+2.45%)
MU   57.79 (-1.21%)
TSLA   857.61 (+7.20%)
AMD   57.31 (+3.60%)
T   38.29 (+0.10%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   389.20 (+2.31%)
DIS   138.93 (-0.44%)
GILD   67.09 (-0.71%)
S&P 500   3,372.59 (-0.22%)
DOW   29,250.19 (-0.50%)
QQQ   235.01 (+0.16%)
AAPL   319.20 (-1.77%)
FB   217.33 (+1.47%)
MSFT   187.43 (+1.12%)
GOOGL   1,524.38 (+0.37%)
AMZN   2,164.46 (+1.39%)
CGC   22.23 (+0.45%)
NVDA   296.89 (+2.45%)
MU   57.79 (-1.21%)
TSLA   857.61 (+7.20%)
AMD   57.31 (+3.60%)
T   38.29 (+0.10%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   389.20 (+2.31%)
DIS   138.93 (-0.44%)
GILD   67.09 (-0.71%)
S&P 500   3,372.59 (-0.22%)
DOW   29,250.19 (-0.50%)
QQQ   235.01 (+0.16%)
AAPL   319.20 (-1.77%)
FB   217.33 (+1.47%)
MSFT   187.43 (+1.12%)
GOOGL   1,524.38 (+0.37%)
AMZN   2,164.46 (+1.39%)
CGC   22.23 (+0.45%)
NVDA   296.89 (+2.45%)
MU   57.79 (-1.21%)
TSLA   857.61 (+7.20%)
AMD   57.31 (+3.60%)
T   38.29 (+0.10%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   389.20 (+2.31%)
DIS   138.93 (-0.44%)
GILD   67.09 (-0.71%)
S&P 500   3,372.59 (-0.22%)
DOW   29,250.19 (-0.50%)
QQQ   235.01 (+0.16%)
AAPL   319.20 (-1.77%)
FB   217.33 (+1.47%)
MSFT   187.43 (+1.12%)
GOOGL   1,524.38 (+0.37%)
AMZN   2,164.46 (+1.39%)
CGC   22.23 (+0.45%)
NVDA   296.89 (+2.45%)
MU   57.79 (-1.21%)
TSLA   857.61 (+7.20%)
AMD   57.31 (+3.60%)
T   38.29 (+0.10%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   389.20 (+2.31%)
DIS   138.93 (-0.44%)
GILD   67.09 (-0.71%)
Log in

Stemline Therapeutics SEC Filings & 10K Form (NASDAQ:STML)

$7.00
+0.12 (+1.74 %)
(As of 02/18/2020 03:09 PM ET)
Today's Range
$6.75
Now: $7.00
$7.02
50-Day Range
$6.38
MA: $7.87
$10.80
52-Week Range
$6.01
Now: $7.00
$18.22
Volume14,117 shs
Average Volume663,819 shs
Market Capitalization$350.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.44

SEC Filings

Stemline Therapeutics (NASDAQ:STML) SEC Filings

DateFilerForm TypeView
02/14/2020
8:34 PM
Bergstein Ivan (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
02/14/2020
8:32 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
8:32 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
8:29 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
8:29 PM
Francomano Robert (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
8:28 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
8:28 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:13 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
02/12/2020
11:58 AM
MANULIFE FINANCIAL CORP (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
02/06/2020
8:10 AM
BlackRock Inc. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
01/24/2020
8:31 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
8:16 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
4:10 PM
Francomano Robert (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/06/2019
6:51 PM
Forman Alan S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
8:36 PM
Forman Alan S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:31 PM
Stemline Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
4:29 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
8:30 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
12:17 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
12:15 PM
Stemline Therapeutics (Filer)
Form 424B5
08/08/2019
5:07 AM
Stemline Therapeutics (Filer)
Form 424B5
08/02/2019
6:30 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
4:17 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:16 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:16 PM
HUME DANIEL (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:15 PM
Cline Darren S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:15 PM
Sard Mark (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:15 PM
Stemline Therapeutics (Issuer)
ZUERBLIS KENNETH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:14 PM
Forman Alan S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:14 PM
BENTSUR RON (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:09 PM
Stemline Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/28/2019
3:30 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
4:01 PM
Stemline Therapeutics (Filer)
Form DEFA14A
06/11/2019
2:44 PM
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (Filed by)
Stemline Therapeutics (Subject)
Form PX14A6G
05/17/2019
8:29 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
8:29 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:11 PM
Stemline Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2019
6:30 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
11:15 PM
Stemline Therapeutics (Filer)
Form EFFECT
04/30/2019
4:04 PM
Stemline Therapeutics (Filer)
Form DEF 14A
04/29/2019
7:32 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
4:00 PM
Stemline Therapeutics (Filer)
Form PRE 14A
03/15/2019
8:01 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
8:00 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
8:00 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
4:08 PM
Stemline Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/15/2019
3:17 PM
Stemline Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2019
8:31 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
8:30 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
8:30 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
8:10 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
8:10 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
8:09 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
3:38 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
02/15/2019
8:31 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
9:17 AM
Polar Capital LLP (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G
02/14/2019
6:49 AM
Consonance Capital Management LP (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
02/13/2019
12:49 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
02/08/2019
7:58 PM
Bergstein Ivan (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
02/08/2019
7:56 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2019
7:54 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
7:52 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
7:50 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
3:15 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2019
3:11 PM
Stemline Therapeutics (Filer)
Form 424B5
01/15/2019
5:06 AM
Stemline Therapeutics (Filer)
Form 424B5
01/11/2019
8:30 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:42 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2018
7:59 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
3:05 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
8:58 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
8:58 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
6:33 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
10:16 AM
FMR LLC (Filed by)
Stemline Therapeutics (Subject)
Form SC 13G/A
08/09/2018
3:16 PM
Stemline Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/02/2018
4:02 PM
Stemline Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/26/2018
7:30 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2018
8:31 PM
Stemline Therapeutics (Issuer)
ZUERBLIS KENNETH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
8:31 PM
Sard Mark (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
8:31 PM
HUME DANIEL (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
8:30 PM
Forman Alan S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
8:30 PM
Cline Darren S (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
8:30 PM
BENTSUR RON (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
3:30 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
3:30 PM
Stemline Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2018
6:59 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2018
8:03 AM
Stemline Therapeutics (Filer)
Form DEFA14A
04/30/2018
8:00 AM
Stemline Therapeutics (Filer)
Form DEF 14A
04/26/2018
5:03 PM
HUME DANIEL (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2018
5:02 PM
Cline Darren S (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2018
5:02 PM
Sard Mark (Reporting)
Stemline Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2018
6:00 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
4:25 PM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
4:24 PM
Stemline Therapeutics (Filer)
Form 424B5
03/16/2018
4:20 PM
Stemline Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/16/2018
7:00 AM
Stemline Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
8:30 PM
Gionco David (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2018
8:30 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2018
8:30 PM
Bergstein Ivan (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2018
8:32 PM
Hoberman Kenneth (Reporting)
Stemline Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel